Home LiteratureArticle Details
PMID: 8895579 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

MDMX: a novel p53-binding protein with some functional properties of MDM2.

The EMBO journal ·Vol. 15 ·No. 19 ·1996-10-01 ·Pages 5349-57

Shvarts A, Steegenga WT, Riteco N, van Laar T, Dekker P, Bazuine M, van Ham RC, van der Houven van Oordt W, Hateboer G, van der Eb AJ, Jochemsen AG

Abstract

Here we report the isolation of a cDNA encoding a new p53-associating protein. This new protein has been called MDMX on the basis of its structural similarity to MDM2, which is especially notable in the p53-binding domain. In addition, the putative metal binding domains in the C-terminal part of MDM2 are completely conserved in MDMX. The middle part of the MDMX and MDM2 proteins shows a low degree of conservation. We can show by co-immunoprecipitation that the MDMX protein interacts specifically with p53 in vivo. This interaction probably occurs with the N-terminal part of p53, because the activity of the transcription activation domain of p53 was inhibited by co-transfection of MDMX. Northern blotting showed that MDMX, like MDM2, is expressed in all tissues tested, and that several mRNAs for MDMX can be detected. Interestingly, the level of MDMX mRNA is unchanged after UV irradiation, in contrast to MDM2 transcription. This observation suggests that MDMX may be a differently regulated modifier of p53 activity in comparison with MDM2. Our study indicates that at least one additional member of the MDM protein family exists which can modulate p53 function.

MeSH Terms
Amino Acid Sequence Animals Base Sequence Cell Line Cloning, Molecular DNA, Complementary/genetics Humans Mice Molecular Sequence Data Nuclear Proteins Organ Specificity Protein Binding Proto-Oncogene Proteins/genetics,metabolism Proto-Oncogene Proteins c-mdm2 RNA, Messenger/analysis Recombinant Fusion Proteins Sequence Analysis, DNA Sequence Homology, Amino Acid Transcription, Genetic/radiation effects Transcriptional Activation/physiology Transfection Tumor Suppressor Protein p53/genetics,metabolism,physiology Ultraviolet Rays
Chemicals
DNA, Complementary Nuclear Proteins Proto-Oncogene Proteins RNA, Messenger Recombinant Fusion Proteins Tumor Suppressor Protein p53 MDM2 protein, human Mdm2 protein, mouse Proto-Oncogene Proteins c-mdm2
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Shvarts A
Laboratory of Molecular Carcinogenesis, Sylvius Laboratories, Leiden University, The Netherlands.
Steegenga W T
Riteco N
van Laar T
Dekker P
Bazuine M
van Ham R C
van der Houven van Oordt W
Hateboer G
van der Eb A J
Jochemsen A G
References (59)
59 references, click to expand
  1. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
    Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7262-6 PMID: 1353891
  2. Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1.
    EMBO J. 1995 Dec 15;14(24):6184-92 PMID: 8557038
  3. Wild-type p53 binds to the TATA-binding protein and represses transcription.
    Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12028-32 PMID: 1465435
  4. T antigen is bound to a host protein in SV40-transformed cells.
    Nature. 1979 Mar 15;278(5701):261-3 PMID: 218111
  5. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.
    Cell. 1979 May;17(1):43-52 PMID: 222475
  6. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells.
    Cell. 1982 Feb;28(2):387-94 PMID: 6277513
  7. Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells.
    Mol Cell Biol. 1985 Nov;5(11):3084-91 PMID: 2943983
  8. Association of human papillomavirus types 16 and 18 E6 proteins with p53.
    Science. 1990 Apr 6;248(4951):76-9 PMID: 2157286
  9. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.
    Cell. 1990 Jul 13;62(1):193-201 PMID: 2114220
  10. Suppression of human colorectal carcinoma cell growth by wild-type p53.
    Science. 1990 Aug 24;249(4971):912-5 PMID: 2144057
  11. Presence of a potent transcription activating sequence in the p53 protein.
    Science. 1990 Aug 31;249(4972):1046-9 PMID: 2144363
  12. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
    Science. 1990 Nov 30;250(4985):1233-8 PMID: 1978757
  13. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
    Cell. 1990 Dec 21;63(6):1129-36 PMID: 2175676
  14. The P-loop--a common motif in ATP- and GTP-binding proteins.
    Trends Biochem Sci. 1990 Nov;15(11):430-4 PMID: 2126155
  15. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.
    EMBO J. 1991 Jun;10(6):1565-9 PMID: 2026149
  16. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
  17. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Nature. 1992 Mar 19;356(6366):215-21 PMID: 1552940
  18. Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest.
    EMBO J. 1992 Jun;11(6):2115-21 PMID: 1600943
  19. Cancer. p53, guardian of the genome.
    Nature. 1992 Jul 2;358(6381):15-6 PMID: 1614522
  20. Amplification of a gene encoding a p53-associated protein in human sarcomas.
    Nature. 1992 Jul 2;358(6381):80-3 PMID: 1614537
  21. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
    Cell. 1992 Jun 26;69(7):1237-45 PMID: 1535557
  22. The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines.
    Carcinogenesis. 1992 Jul;13(7):1273-5 PMID: 1322252
  23. Regulation of the human hsp70 promoter by p53.
    Science. 1993 Jan 1;259(5091):84-7 PMID: 8418500
  24. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
    Cell. 1993 Jan 29;72(2):211-22 PMID: 8425218
  25. mdm2 expression is induced by wild type p53 activity.
    EMBO J. 1993 Feb;12(2):461-8 PMID: 8440237
  26. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.
    Nature. 1993 Apr 29;362(6423):857-60 PMID: 8479525
  27. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma.
    Oncogene. 1993 May;8(5):1109-17 PMID: 8386823
  28. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
    Cancer Res. 1993 Jun 15;53(12):2736-9 PMID: 8504413
  29. Physical and functional interaction between WT1 and p53 proteins.
    Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5100-4 PMID: 8389468
  30. p53 binds to the TATA-binding protein-TATA complex.
    J Biol Chem. 1993 Jun 25;268(18):13062-7 PMID: 8514746
  31. The p53-mdm-2 autoregulatory feedback loop.
    Genes Dev. 1993 Jul;7(7A):1126-32 PMID: 8319905
  32. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.
    Mol Cell Biol. 1993 Nov;13(11):6849-57 PMID: 8413278
  33. The human MDM-2 oncogene is overexpressed in leukemias.
    Blood. 1993 Nov 1;82(9):2617-23 PMID: 8219216
  34. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.
    Oncogene. 1993 Dec;8(12):3411-6 PMID: 8247544
  35. The mdm-2 gene is induced in response to UV light in a p53-dependent manner.
    Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11623-7 PMID: 8265599
  36. The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?
    Bioessays. 1993 Oct;15(10):689-90 PMID: 7506024
  37. Physical and functional interaction between wild-type p53 and mdm2 proteins.
    Mol Cell Biol. 1994 Feb;14(2):1171-8 PMID: 8289798
  38. The p53-associated protein MDM2 contains a newly characterized zinc-binding domain called the RING finger.
    Trends Biochem Sci. 1994 May;19(5):198-9 PMID: 8048160
  39. Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells.
    Oncogene. 1994 Sep;9(9):2745-50 PMID: 8058341
  40. Altered patterns of MDM2 and TP53 expression in human bladder cancer.
    J Natl Cancer Inst. 1994 Sep 7;86(17):1325-30 PMID: 8064890
  41. Oncogene amplification in urothelial cancers with p53 gene mutation or MDM2 amplification.
    J Natl Cancer Inst. 1994 Sep 7;86(17):1331-5 PMID: 8064891
  42. Database of p53 gene somatic mutations in human tumors and cell lines.
    Nucleic Acids Res. 1994 Sep;22(17):3551-5 PMID: 7937055
  43. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.
    Genes Dev. 1994 Aug 1;8(15):1739-49 PMID: 7958853
  44. Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene.
    Blood. 1995 Mar 15;85(6):1608-14 PMID: 7888679
  45. Functional inactivation but not structural mutation of p53 causes liver cancer.
    Nat Genet. 1995 Jan;9(1):41-7 PMID: 7704023
  46. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.
    Proc Natl Acad Sci U S A. 1995 May 9;92(10):4407-11 PMID: 7753819
  47. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas.
    Blood. 1995 Jun 1;85(11):3239-46 PMID: 7756655
  48. Human TAFII31 protein is a transcriptional coactivator of the p53 protein.
    Proc Natl Acad Sci U S A. 1995 May 23;92(11):5154-8 PMID: 7761466
  49. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.
    Nature. 1995 Jun 22;375(6533):691-4 PMID: 7791903
  50. BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation.
    EMBO J. 1995 Jul 3;14(13):3159-69 PMID: 7621829
  51. A functional p53-responsive intronic promoter is contained within the human mdm2 gene.
    Nucleic Acids Res. 1995 Jul 25;23(14):2584-92 PMID: 7651818
  52. Human chromosome 11 suppresses the tumorigenicity of adenovirus transformed baby rat kidney cells: involvement of the Wilms' tumor 1 gene.
    Int J Cancer. 1995 Sep 27;63(1):76-85 PMID: 7558457
  53. Distinct modulation of p53 activity in transcription and cell-cycle regulation by the large (54 kDa) and small (21 kDa) adenovirus E1B proteins.
    Virology. 1995 Oct 1;212(2):543-54 PMID: 7571424
  54. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.
    Nature. 1995 Nov 9;378(6553):203-6 PMID: 7477326
  55. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.
    Nature. 1995 Nov 9;378(6553):206-8 PMID: 7477327
  56. Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line.
    Eur J Cancer. 1995;31A(4):520-3 PMID: 7576957
  57. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Mol Med. 1995 Jan;1(2):142-52 PMID: 8529093
  58. GM1492 human diploid skin fibroblasts lack the p53-dependent G1 cell-cycle checkpoint.
    Biochem Biophys Res Commun. 1995 Dec 26;217(3):769-76 PMID: 8554597
  59. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis.
    Nature. 1992 Sep 24;359(6393):288-94 PMID: 1406932
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1996-10-01
Pages
5349-57
Language
English
Region
England
NLM ID
8208664
PMCID
PMC452278
Subset
IM
Databases
GENBANK
AF007110
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]